Nashoba Biotechnology
Nashoba Biotechnology, based in Acton, MA, is focused on reprogramming the tumor microenvironment to develop a new class of anticancer drugs. The company is dedicated to enhancing the efficacy of existing immunotherapies, particularly immune checkpoint inhibitors, by targeting specific glycan structures within the tumor microenvironment.
With a mission to improve patient outcomes, Nashoba Biotechnology aims to provide innovative first-in-class medicines that work synergistically with other therapeutic agents to increase overall survival rates across various cancer types. Their research highlights the critical role of non-cancerous components in tumors and seeks to alter molecular conversations that drive cancer progression.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.